BioSpace News Archive

Code Ocean, the developer of a first-of-its-kind, computational-research laboratory SaaS platform for scientific collaboration and discovery, today announced $16.5 million in Series-B funding co-led by Battery Ventures and M12, Microsoft’s Venture Fund.

Oxurion NV (Euronext Brussels: OXUR) (the “Company” or “Oxurion”), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, held its extraordinary shareholders’ meeting on May 24, 2022.

StageZero Life Sciences, Ltd. announced that it has partnered with DiagnoseAtHome to make the Company’s multi-cancer blood test, Aristotle®, available to DiagnoseAtHome’s patients in Canada and the USA.

Biosenta Inc. is developing environmentally friendly biocidal particles that are successfully tested against infectious bacteria growing on common surfaces.

Eli Lilly and Company (NYSE: LLY) plans to expand its manufacturing footprint in Indiana by investing $2.1 billion in two new manufacturing sites at Indiana’s LEAP Lebanon Innovation and Research District in Boone County.

Phenomix Sciences, a precision obesity biotechnology company, announces the launch of its biobanking registry and outcomes study.

A new study with TikoMed’s platform lead clinical drug candidate ILB®, provides positive safety and tolerability results and the first clinical evidence of encouraging clinical efficacy of ILB® in the treatment of amyotrophic lateral sclerosis (ALS).

A recently published peer-reviewed study comparing acute changes in the upper body with pulsed direct current and high load exercises found that short-term training with the Neubie® neuromuscular electrical stimulation (NMES) device results in similar responses as traditional high load training in areas of increased muscle thickness.

Galapagos NV (Euronext & Nasdaq: GLPG) will present 11 abstracts at the European League Against Rheumatism (EULAR) congress 2022, 01-04 June, taking place in Copenhagen, Denmark.

MDxHealth Announces Resultsof its Annual and Extraordinary General Shareholders’ Meetings and Resignation of Director